Population Exposure-Response Modeling of the Effects of Apomorphine Sublingual Film on QTc in Patients With Parkinson's Disease and "OFF" Episodes

被引：0
|
作者：
Agbo, F.
Chiu, Y.
Chapel, S.
Galluppi, G.
Blum, D.
Navia, B.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
762
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [21] A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson's disease 'OFF' episodes
    Caughman, Christopher Y.
    Factor, Stewart
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (02) : 169 - 177
  • [22] Long-term Safety and Tolerability of Apomorphine Sublingual Film in Patients with Parkinson's Disease and "OFF" Episodes
    Ondo, William
    Ellenbogen, Aaron L.
    Isaacson, Stuart
    Espay, Alberto J.
    Bhargava, Parul
    Worden, MaryAlice
    Blum, David
    Navia, Bradford
    NEUROTHERAPEUTICS, 2019, 16 (03) : 913 - 913
  • [23] Budget Impact of Apomorphine Sublingual Film for On-Demand Treatment of Patients With Parkinson's Disease and "OFF" Episodes
    Thach, A.
    Kirson, N.
    Zichlin, M.
    Dieye, I.
    Pappert, E.
    Williams, G.
    MOVEMENT DISORDERS, 2020, 35 : S427 - S427
  • [24] Apomorphine Sublingual Film for On-Demand Treatment of "OFF" Episodes in Patients With Parkinson's Disease: Impact on Dyskinesia
    Klos, K.
    Hui, J.
    Robottom, B.
    Bhargava, P.
    Navia, B.
    MOVEMENT DISORDERS, 2020, 35 : S404 - S404
  • [25] Motor response with apomorphine sublingual film and levodopa in patients with OFF episodes
    Isaacson, Stuart H.
    Bowling, Alyssa
    Zhang, Ian
    Pappert, Eric
    Stocchi, Fabrizio
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (02) : 75 - 84
  • [26] ANTIEMETICS MAY NOT BE NECESSARY FOR TITRATION OF APOMORPHINE SUBLINGUAL FILM FOR THE TREATMENT OF "OFF" EPISODES IN PARKINSON'S DISEASE
    Hauser, R. A.
    Factor, S. A.
    Ondo, W. G.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 42 - 43
  • [27] APOMORPHINE SUBLINGUAL FILM FOR "OFF" EPISODES IN PARKINSON'S DISEASE: LONG-TERM SAFETY AND EFFICACY
    Factor, S.
    Ondo, W. G.
    Isaacson, S.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 41 - 42
  • [28] Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease 'OFF' episodes
    Thach, Andrew
    Zichlin, Miriam L.
    Kirson, Noam
    Yang, Karen
    Gaburo, Katherine
    Pappert, Eric
    Mehta, Darshan
    Williams, G. Rhys
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (04) : 285 - 295
  • [29] Long-Term Safety and Efficacy of Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease
    Factor, S.
    Ondo, W.
    Isaacson, S.
    Zhang, I.
    Pappert, E.
    Navia, B.
    MOVEMENT DISORDERS, 2021, 36 : S171 - S171
  • [30] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease: Impact of Concomitant Antiemetics on Nausea and Vomiting
    Hauser, R.
    Factor, S.
    Ondo, W.
    Zhang, I.
    Pappert, E.
    Navia, B.
    MOVEMENT DISORDERS, 2021, 36 : S175 - S175
12345